Core Viewpoint - Chao Yan Co., Ltd. has shown a slight decline in stock price and trading volume, with notable financing activities indicating investor sentiment and market dynamics [1][2]. Financing and Trading Activity - On October 22, Chao Yan Co., Ltd. experienced a stock price drop of 0.16% with a trading volume of 32.10 million yuan. The financing buy-in amounted to 2.52 million yuan, while financing repayment was 2.54 million yuan, resulting in a net financing outflow of 0.018 million yuan. The total financing and securities lending balance reached 95.12 million yuan [1]. - The current financing balance stands at 94.95 million yuan, representing 6.69% of the circulating market value. In terms of securities lending, 1,500 shares were repaid, and 600 shares were sold, with a selling amount of 14,600 yuan based on the closing price [1]. Company Overview - Chao Yan Co., Ltd., established on November 15, 1982, is located in Shantou, Guangdong Province. The company specializes in the research, development, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, recognized as a national key high-tech enterprise. The revenue composition includes 71.16% from medical ultrasound, 17.30% from industrial ultrasound, 5.72% from accessories, 4.56% from X-ray, and 1.26% from other sources [1]. Financial Performance - For the first half of 2025, Chao Yan Co., Ltd. reported a revenue of 184 million yuan, reflecting a year-on-year growth of 15%. The net profit attributable to shareholders reached 68.45 million yuan, marking an 18.5% increase compared to the previous period [2]. Shareholder and Institutional Holdings - As of June 30, 2025, the number of shareholders for Chao Yan Co., Ltd. was 22,300, a decrease of 16.65% from the previous period. The average number of circulating shares per shareholder increased by 19.98% to 2,456 shares [2]. - The top ten circulating shareholders include new entrants such as Huabao Zhongzheng Medical ETF and Southern Zhongzheng 1000 ETF, with significant holdings of 1.91 million shares and 514,500 shares, respectively. Hong Kong Central Clearing Limited is the fourth-largest shareholder, increasing its holdings by 21,600 shares [3].
超研股份10月22日获融资买入252.33万元，融资余额9495.03万元